Fabrication, optimization, andin vitroevaluation of docetaxel-loaded nanostructured lipid carriers for improved anticancer activity
Authors:
- 27 June 2019
- journal article
- research article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 30 (2) , 182-196
Abstract
Lung cancer is the leading cause of cancer-related deaths in both men and women worldwide. It is the leading cancer killer in both men and women in every Ethnic Group. A major problem associated with chemotherapies against their lung cancer is the lack of selective toxicity, which results in a narrow therapeutic index thereby compromising clinical prognosis. To circumvent these challenges, the present investigation sought to develop a docetaxel-loaded nanostructured lipid carrier system (DTX-NLCS) for the treatment of lung cancer. A 3-factor/3-level Box-Behnken Design was applied to systematically optimize the DTX-NLCS parameters. The amount of drug, emulsifier concentration, and homogenization speed was selected as independent variables, while the particle size and % entrapment efficiency (%EE) were selected as dependent variables. The optimized batch parameters were 29.81 mg drug, 19.97% w/w emulsifier, and 13 200 (rpm) speed of homogenization with a mean particle size of 154.1 ± 3.13 nm and a mean %EE of 86.12 ± 3.48%. The in vitro lipolysis experiments revealed that the optimized DTX-NLCs were stabilized by 10% w/w PEG 4000 mono-stearate and exhibited an anti-lipolytic effect. Furthermore, the in vitro gastrointestinal stability studies (at pH-1.2, pH-4.5, pH-6.8, and pH-7.4) revealed that the optimized developed system could withstand various GI tract media. The in vitro dissolution studies depicted a pH-independent controlled-release consistent with the Weibull model. In vitro cytotoxicity studies using NCI-H460 cell lines further revealed that there was a reduction in IC50 values in the DTX-NLCS treated cells as compared to those treated with the pure drug, indicating an improved efficiency for the developed system. Graphical AbstractKeywords
Funding Information
- Nirma University, Ahmedabad (NU/Ph.D./Major Res Pro/IP/16–17/669)
- Department of Science and Technology (DST), Fund for Improvement of S&T Infrastructure (SR/FST/LSI-607/)
This publication has 48 references indexed in Scilit:
- In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challengesDrug Delivery and Translational Research, 2013
- Preparation and characterization of solid lipid nanoparticle-based nasal spray of budesonideDrug Delivery and Translational Research, 2012
- PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epitheliumBiomaterials, 2012
- Development of Lipid-Based Nanoparticles for Enhancing the Oral Bioavailability of PaclitaxelAAPS PharmSciTech, 2011
- The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel TherapeuticsJournal of Pharmaceutical Sciences, 2008
- Taste masking microspheres for orally disintegrating tabletsInternational Journal of Pharmaceutics, 2008
- Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brainJournal of Pharmacy and Pharmacology, 2007
- Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storageEuropean Journal of Pharmaceutics and Biopharmaceutics, 2006
- Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials, 2005
- Phagocytic Uptake and Cytotoxicity of Solid Lipid Nanoparticles (SLN) Sterically Stabilized with Poloxamine 908 and Poloxamer 407Journal of Drug Targeting, 1996